T1	FactorValue 527 550	normal or tumor tissues
T2	Disease 1002 1031	triple-negative breast cancer
T3	Disease 1065 1121	omental metastasis from high-grade serous ovarian cancer
T4	Disease 1126 1140	normal omentum
T5	NumberOfSamples 4193 4194	2
T6	NumberOfSamples 4240 4241	2
T7	Disease 1036 1059	adjacent mammary tissue
T8	PrecursorMassTolerance 10361 10367	10 ppm
T9	FragmentMassTolerance 10403 10409	15 mmu
T10	NumberOfMissedCleavages 10443 10446	two
T11	Modification 10499 10530	carbamidomethylation of cystein
A1	Modification T11 fixed
T12	Modification 10565 10584	oxidized methionine
A2	Modification T12 variable
T13	Modification 10586 10611	deamidation of asparagine
A3	Modification T13 variable
T14	Modification 10613 10668	pyro-glutamic acid modification at N-terminal glutamine
A4	Modification T14 variable
T15	Modification 10674 10709	hydroxylation of lysine and proline
A5	Modification T15 variable
T16	Separation 8328 8369	reversed-phase HPLC using an EASY-nLC1000
T17	GradientTime 8532 8539	140 min
T18	NumberOfFractions 9787 9789	15
T19	FractionationMethod 9363 9390	high-pH reversed-phase HPLC
T20	AlkylationReagent 6884 6897	iodoacetamide
T21	CleavageAgent 7245 7250	Lys-C
T22	CleavageAgent 7348 7355	trypsin
T23	ReductionReagent 6756 6770	dithiothreitol
T24	AcquisitionMethod 8949 8963	data-dependent
T25	OrganismPart 99 119	extracellular matrix
T26	OrganismPart 121 124	ECM
*	Equiv T25 T26
T27	EnrichmentMethod 2480 2497	decellularization
T28	IonizationType 8556 8572	nanoelectrospray
T29	Instrument 8581 8608	QExactive mass spectrometer
T30	CollisionEnergy 9201 9203	28
T31	Organism 10281 10293	Homo sapiens
T32	OriginSiteDisease 1018 1024	breast
T33	OriginSiteDisease 1107 1114	ovarian
